Access Statistics for Dana P. Goldman

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Economic Evaluation of the War on Cancer 0 0 0 97 0 7 14 374
Are the Young Becoming More Disabled? 0 0 0 93 0 0 9 355
Can Patient Self-Management Help Explain the SES Health Gradient? 0 0 0 161 1 3 12 630
Criminal Prosecution and HIV-related Risky Behavior 0 0 0 27 0 5 20 273
Disentangling Moral Hazard and Adverse Selection in Private Health Insurance 0 0 1 52 3 18 34 158
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 23 0 4 13 49
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 85 0 2 10 45
Employee Responses to Health Insurance Premium Increases 0 0 0 23 0 4 8 183
Food Prices and the Dynamics of Body Weight 0 0 0 71 0 5 12 244
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 0 2 10 645
Health Care Spending: Historical Trends and New Directions 0 0 0 41 0 4 13 91
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 1 3 10 201
Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician 0 0 0 3 0 3 10 56
Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand 0 0 0 127 1 7 20 473
How Costly Is Hospital Quality? A Revealed-Preference Approach 0 0 0 91 0 1 7 310
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 3 0 4 11 50
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 95 0 2 13 174
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 0 0 3 11 20
Integrated Insurance Design in the Presence of Multiple Medical Technologies 0 0 0 23 0 3 6 176
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 35 0 2 12 134
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 0 1 6 270
International Differences in Longevity and Health and their Economic Consequences 0 0 0 55 1 5 18 188
Market Evidence of Misperceived Prices and Mistaken Mortality Risks 0 0 0 51 0 4 10 304
Medical Expenditure Risk and Household Portfolio Choice 0 0 0 76 0 2 14 349
Medical Expenditure Risk and Household Portfolio Choice 0 0 0 4 0 3 6 91
Moral Hazard and Adverse Selection in Private Health Insurance 0 0 2 21 3 16 32 99
Prescription Drug Coverage and Elderly Medicare Spending 0 0 0 49 0 6 15 360
Price Variation in Markets with Homogeneous Goods The Case of Medigap 0 0 0 1 0 0 3 23
Price Variation in Markets with Homogeneous Goods: The Case of Medigap 0 0 0 43 1 1 6 271
Productivity Growth in Treating a Major Chronic Health Condition 0 0 0 0 1 5 13 17
Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 0 0 0 9 10
Socioeconomic Differences in the Adoption of New Medical Technologies 0 1 1 66 0 6 12 279
Terminal Care and The Value of Life Near Its End 0 0 3 212 0 8 21 715
The Effects of Product Liability Exemption in the Presence of the FDA 0 0 0 19 0 4 7 203
The Effects of Relative Food Prices on Obesity -- Evidence from China: 1991-2006 0 0 0 81 0 0 12 233
The Effects of Relative Food Prices on Obesity – Evidence from China: 1991-2006 0 0 0 31 0 3 14 160
The Future of the Elderly Population Health Status: Filling a Knowledge Gap 0 0 0 34 1 6 19 78
The Link Between Public and Private Insurance and HIV-Related Mortality 0 0 0 79 0 5 10 496
The Reallocation of Compensation in Response to Health Insurance Premium Increases 0 0 0 52 0 1 9 348
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 0 29 0 5 14 179
Understanding Health Disparities Across Education Groups 0 1 2 400 0 2 13 1,716
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 36 0 1 5 116
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 43 0 1 10 235
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 50 0 3 14 192
Wage and Benefit Changes in Response to Rising Health Insurance Costs 0 0 0 54 0 4 14 308
Total Working Papers 0 2 9 2,723 13 174 561 11,881

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Reexamination of the Costs of Medical R&D Regulation 0 0 1 14 0 1 11 78
A Theory of Health Disparities and Medical Technology 0 0 2 147 1 7 25 637
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 15 0 1 5 107
An economic evaluation of the war on cancer 0 2 2 110 0 6 16 596
Are Biopharmaceutical Budget Caps Good Public Policy? 0 1 2 14 0 1 12 84
Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson’s disease: Retrospective cohort analysis 0 0 0 0 1 2 4 4
Can patient self-management explain the health gradient? revisited: A response to Maitra 0 0 0 12 0 2 8 47
Can the ACA Improve Population Health? 0 0 0 14 0 5 13 81
Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior 0 0 0 8 0 0 6 102
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 0 27 0 9 19 127
Digesting the doughnut hole 0 0 1 7 0 4 13 66
Disability Forecasts and Future Medicare Costs 0 0 1 35 1 3 9 282
Disentangling moral hazard and adverse selection in private health insurance 0 2 5 18 2 15 49 115
Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context 0 0 0 1 0 1 8 16
Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? 0 0 0 4 0 2 13 72
Do Statins Reduce the Health and Health Care Costs of Obesity? 0 0 0 7 0 3 6 38
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 2 1 5 10 28
Does age or life expectancy better predict health care expenditures? 0 0 1 88 2 2 8 309
Effect of COVID-19 vaccine allocation strategies on vaccination refusal: a national survey 0 0 0 1 1 2 6 12
Effect of Insurance on Mortality in an HIV-Positive Population in Care 0 0 0 15 0 4 9 94
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 0 6 10 30
Estimated prevalence of undiagnosed atrial fibrillation in the United States 0 0 0 0 1 4 7 15
Geographic Variation in Health Care: The Role of Private Markets 0 0 0 75 1 5 13 432
Geographic variation in the delivery of high-value inpatient care 0 0 0 0 0 2 10 18
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 1 8 32
HIV Breakthroughs and Risky Sexual Behavior 0 0 0 166 0 2 14 931
Health Care Spending: Historical Trends and New Directions 0 0 0 7 0 4 12 92
Health and Health Care of Medicare Beneficiaries in 2030 0 0 1 9 2 8 16 69
How Costly is Hospital Quality? A Revealed‐Preference Approach 0 0 0 7 0 2 18 81
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 41 2 8 20 274
IT IS TIME FOR UNIVERSAL COVERAGE WITHOUT BREAKING THE BANK 0 0 1 8 0 4 7 28
Improved survival for individuals with common chronic conditions in the Medicare population 0 0 0 0 0 0 4 9
Integrated Insurance Design in the Presence of Multiple Medical Technologies 0 0 0 23 0 3 11 256
MEDICAL EXPENDITURE RISK AND HOUSEHOLD PORTFOLIO CHOICE 0 0 0 0 2 3 13 199
MEDICARE†FOR†ALL: NOT OUR ONLY OPTION FOR UNIVERSAL COVERAGE 0 0 0 1 0 3 7 19
Managed Care as a Public Cost-Containment Mechanism 0 0 1 49 1 4 10 528
Market evidence of misperceived mortality risk 0 0 0 10 0 0 5 37
Medical Expenditure Measures in the Health and Retirement Study 0 0 0 34 0 1 5 125
Part D Formulary and Benefit Design as a Risk-Steering Mechanism 0 0 0 26 0 2 8 141
Patient Cost-Sharing and Healthcare Spending Growth 0 0 1 66 1 7 19 292
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 0 2 51 0 0 10 194
Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors 0 0 0 3 1 2 14 53
Predicting quantity and quality of life with the Future Elderly Model 0 0 0 2 0 3 12 25
Prescription Drug Coverage and Medicare Spending among U.S. Elderly 0 0 0 0 1 6 12 12
Prescription Drug Coverage and Medicare Spending among U.S. Elderly&ast 0 0 0 16 0 0 4 85
Price Regulation in Secondary Insurance Markets 0 1 2 15 0 2 15 97
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 0 41 0 0 11 165
Queuing for Surgery: Is the U.S. or Canada Worse Off? 0 0 0 148 0 1 8 1,134
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 2 12 16 34
Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards 0 0 0 3 0 5 11 62
Racial and ethnic disparities in medication adherence among privately insured patients in the United States 0 0 0 2 0 1 6 16
Socioeconomic Differences in the Adoption of New Medical Technologies 0 0 0 34 0 1 13 245
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 0 72 1 5 14 310
The Costs of A Medicare Prescription Drug Benefit 0 0 0 61 0 0 5 666
The Fiscal Consequences of Trends in Population Health 1 1 1 16 2 5 12 77
The Future of US Health Care: Is Medicare Really Better at “Saving” Money? 0 0 0 29 0 0 1 96
The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare 0 0 0 42 0 1 6 185
The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older 0 0 0 0 0 3 9 11
The Returns to Preventing Chronic Disease in Europe and the United States 0 0 0 29 0 1 6 50
The Value of Diagnostic Testing in Personalized Medicine 0 0 1 61 0 2 6 230
The Value of Elderly Disease Prevention 0 0 0 116 0 3 7 446
The association between observed mobility and quality of life in the near elderly 0 0 0 0 0 2 12 15
The benefits of risk factor prevention in Americans aged 51 years and older 0 0 0 1 1 4 7 18
The economics of alternative payment models for pharmaceuticals 0 0 0 9 0 3 13 51
The effects of benefit design and managed care on health care costs 0 0 0 28 1 2 6 99
The future of the elderly population health status: Filling a knowledge gap 0 0 0 4 0 0 13 27
The increasing value of education to health 0 0 0 23 1 3 7 108
The link between public and private insurance and HIV-related mortality 0 0 0 33 0 1 5 303
The long-term impact of functional disability on hospitalization spending in Singapore 0 0 0 4 0 2 21 54
The potential impact of comparative effectiveness research on U.S. Health Care expenditures 0 0 0 0 1 5 13 35
The reallocation of compensation in response to health insurance premium increases 0 0 0 13 0 4 11 176
The value of medical and pharmaceutical interventions for reducing obesity 0 0 0 15 0 3 10 107
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 26 0 5 10 110
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 21 0 3 9 133
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 0 1 0 1 10 27
Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000 0 0 0 8 1 2 8 88
Total Journal Articles 1 7 25 1,994 31 237 820 12,047
1 registered items for which data could not be found

Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Economic Dimensions of Personalized and Precision Medicine 0 0 0 0 1 5 18 73
Frontiers in Health Policy Research, Volume 10 0 0 0 0 1 3 16 58
Frontiers in Health Policy Research, volume 12 0 0 0 0 0 5 12 81
Frontiers in Health Policy Research, volume 13 0 0 0 0 0 4 10 69
Total Books 0 0 0 0 2 17 56 281

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis 0 0 0 24 2 6 15 98
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 0 0 0 6 35
Disability Forecasts and Future Medicare Costs 0 0 0 23 0 4 11 118
Disability and Spending Growth 0 0 0 5 1 3 6 35
Food Prices and the Dynamics of Body Weight 1 1 1 15 1 4 15 87
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 0 0 3 104 0 1 13 270
Introduction to "Economic Dimensions of Personalized and Precision Medicine" 0 0 0 23 1 2 6 95
Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 4 1 4 9 41
The Effects of Product Liability Exemption in the Presence of the FDA 0 0 0 24 0 5 13 143
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 0 1 7 10 50
Total Chapters 1 1 4 222 7 36 104 972

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-06-04